X0306 4 2016-12-21 0 0001566469 NantHealth, Inc. NH 0001189020 SOON-SHIONG PATRICK C/O NANTWORKS, LLC 9920 JEFFERSON BLVD. CULVER CITY CA 90232 1 1 1 0 Chairman and CEO 0001629222 Cambridge Equities, LP 9920 JEFFERSON BLVD. CULVER CITY CA 90232 0 0 1 0 0001629186 MP 13 Ventures, LLC 9920 JEFFERSON BLVD. CULVER CITY CA 90232 0 0 1 0 5.50% Convertible Senior Notes due 2021 2016-12-21 4 P 0 10000000 10000000.00 A 2021-12-15 Common Stock 823893 10000000.00 I See Footnote The initial conversion rate of the 5.50% Convertible Senior Notes due 2021 (the "Notes") is 82.3893 shares of common stock per $1,000 principal amount of Notes (which is equivalent to an initial conversion price of approximately $12.14 per share), subject to adjustment pursuant to the terms of the Notes. The Notes will be convertible at the option of the reporting persons only upon the satisfaction of certain conditions prior to the close of business on the business day immediately preceding September 15, 2021. Thereafter, the Notes will be convertible at the option of the reporting persons at any time or after September 15, 2021 until the close of business on the business day immediately preceding the maturity date. The Notes will be convertible into cash, shares of the issuer's common stock, or a combination thereof, at the issuer's election. The Notes are held by Cambridge Equities, LP ("Cambridge Equities"), an entity affiliated with . MP 13 Ventures, LLC ("MP 13 Ventures") is the general partner of Cambridge Equities and may be deemed to have beneficial ownership of the option held by Cambridge Equities. The reporting person is the sole member of MP 13 Ventures and has voting and dispositive power over the option held by Cambridge Equities. /s/ Patrick Soon-Shiong and /s/ Charles Kenworthy, Manager of MP 13 Ventures, on behalf of itself and as General Partner of Cambridge Equities 2016-12-23